Metabolic syndrome is a condition which is recognized by abdominal obesity, dyslipidemia, hyperglycemia, and hypertension. Curcumin has beneficial effects such as antioxidant and anti-inflammatory effects. nanomcielle curcumin will be used in this study because of the low bioavailability , fast metabolism and low absorption of curcumin powder. Therefore, this study is planned to determine the effects of supplementation of nanomicelle curcumin on glycemic control, serum lipid profile ,blood pressure and anthropometric measurements in patients with metabolic syndrome.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
hemoglobin A1c (HbA1c)
Timeframe: 12 weeks
serum glucose
Timeframe: 12weeks
serum insulin
Timeframe: 12weeks
homeostatic model assessment of insulin resistance(HOMA-IR)
Timeframe: 12weeks
homeostatic model assessment of beta cell(HOMA-B)
Timeframe: 12weeks
serum triglyceride (TG)
Timeframe: 12 weeks
serum total Cholesterol
Timeframe: 12 weeks
serum LDL-C
Timeframe: 12 weeks
serum HDL-C
Timeframe: 12 weeks
systolic blood pressure
Timeframe: 12 weeks
diastolic blood pressure
Timeframe: 12 weeks
serum curcumin
Timeframe: 12 weeks